Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo

Fig. 1

CT & MRI results from BALB/c nude mouse model. Imaging results from tumor-bearing mice inoculated with A549 cells. CT scans (top) show that with G5-AuNP-Gd-Trastuzumab (red box), there is a significant difference in signal intensity when compared to non-targeted G5-AuNP-Gd at 4 h after conjugate administration. MRI (showed in the bottom panel), also demonstrates a significant difference between G5-AuNP-Gd-Trastuzumab (red box) and G5-AuNP-Gd at the 4 h time point, P = 0.05. SEM was used for error bars, n = 6

Back to article page